Nuvectis Pharma, Inc. (NVCT)
23.92
+0.86
(+3.73%)
USD |
NASDAQ |
Sep 02, 16:00
24.00
+0.08
(+0.33%)
After-Hours: 20:00
Nuvectis Pharma Cash and Short Term Investments (Quarterly) : 22.16M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.16M |
| March 31, 2026 | 25.13M |
| December 31, 2025 | 31.63M |
| September 30, 2025 | 35.44M |
| June 30, 2025 | 26.79M |
| March 31, 2025 | 29.86M |
| December 31, 2024 | 18.53M |
| September 30, 2024 | 17.17M |
| June 30, 2024 | 18.12M |
| March 31, 2024 | 19.46M |
| December 31, 2023 | 19.13M |
| Date | Value |
|---|---|
| September 30, 2023 | 22.06M |
| June 30, 2023 | 24.60M |
| March 31, 2023 | 15.47M |
| December 31, 2022 | 19.99M |
| September 30, 2022 | 23.64M |
| June 30, 2022 | 13.57M |
| March 31, 2022 | 16.69M |
| December 31, 2021 | 5.742M |
| September 30, 2021 | 6.809M |
| June 30, 2021 | 7.214M |
| March 31, 2021 | 0.00 |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Decoy Therapeutics, Inc. | 8.289M |
| Unicycive Therapeutics, Inc. | 61.42M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| Anika Therapeutics, Inc. | 38.41M |